Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021
Period Ending	Dec 31, 2021
Net Income	-40.62M
Depreciation & Amortization	25K
Stock-Based Compensation	668K
Other Working Capital	1.21M
Other Non-Cash Items	3.39M
Deferred Income Tax	n/a
Change in Working Capital	-7.25M
Operating Cash Flow	-43.79M
Capital Expenditures	-25K
Cash Acquisitions	n/a
Purchase of Investments	n/a
Sales Maturities Of Investments	n/a
Other Investing Acitivies	n/a
Investing Cash Flow	-25K
Debt Repayment	n/a
Common Stock Repurchased	n/a
Dividend Paid	-7.74M
Other Financial Acitivies	70.73M
Financial Cash Flow	62.99M
Net Cash Flow	19.18M
Free Cash Flow	-43.81M